Somte PSG portable sleep-testing systems from Compumedics USA Inc were chosen as part of the Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study.
The research will further investigate the link between sleep disorders and cardiovascular disease in various ethnic and racial populations.
Somte PSG was chosen because of its ability to record complex sleep studies in the home environment with acceptable participant burden, according to Dr Susan Redline, professor of medicine at Harvard Medical School and the senior investigator for the MESA Sleep Study.
The contract is worth approximately $300,000 and supports Compumedics’ technology and product offering for the relatively new home sleep study (HST) market, which is undergoing double digit growth with global HST revenues already exceeding US $20 million.
Patients enrolled in the MESA Sleep Study will be monitored from the Reading Center located at Brigham and Women’s Hospital in Boston. The MESA was established by the National Institutes of Health in 2000 with the aims of identifying ethnic and racial differences in risk factors and subclinical and clinical cardiovascular disease. This new MESA Sleep Study has been funded to further understand these risks.
